Analysis of measles-mumps-rubella (MMR) titers of recovered COVID-19 patients

Jeffrey Gold, William Baumgartl, Ramazan Okyay, Warren Licht, Paul Fidel, Mairi Noverr, Larry Tilley, David Hurley, Balázs Rada & John Ashford
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with MMR II. We divided 80 subjects into two groups, comparing MMR titers to recent COVID-19 severity. The MMR II group consisted of 50 subjects who would primarily have MMR antibodies from the MMR II vaccine, and a comparison group of 30...

Registration Year

  • 2020
    1

Resource Types

  • Dataset
    1

Affiliations

  • Stanford University
    1
  • University of Georgia
    1
  • Louisiana State University Health Sciences Center New Orleans
    1
  • Kahramanmaraş Sütçü İmam University
    1
  • Tulane University
    1
  • Brown University
    1